These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22952496)

  • 1. Afebrile Neuroleptic Malignant Syndrome associated with Fluphenazine decanoate: A case report.
    Assareh M; Habibi LK
    Iran J Psychiatry; 2010; 5(2):78-80. PubMed ID: 22952496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neuroleptic malignant syndrome.
    Smego RA; Durack DT
    Arch Intern Med; 1982 Jun; 142(6):1183-5. PubMed ID: 6124221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid symptom control in neuroleptic malignant syndrome with electroconvulsive therapy: A case report.
    Katzell L; Beydler E; Dos Santos AS; Vijayvargiya R; Carr BR
    Front Psychiatry; 2023; 14():1143407. PubMed ID: 37032940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
    Khouri C; Planès S; Logerot S; Villier C; Mallaret M
    Encephale; 2016 Jun; 42(3):277-80. PubMed ID: 26923996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluphenazine-induced neuroleptic malignant syndrome in a schizophrenic patient.
    Aruna AS; Murungi JH
    Ann Pharmacother; 2005 Jun; 39(6):1131-5. PubMed ID: 15840734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute catatonic syndrome after neuroleptic malignant syndrome].
    Benjelloun G; Jehel L; Abgrall G; Pelissolo A; Allilaire J
    Encephale; 2005; 31(6 Pt 1):705-9. PubMed ID: 16462690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuroleptic malignant syndrome: a rare long lasting case report].
    Lemos J; Mós M; Monteiro A; Henriques P
    Acta Med Port; 2010; 23(6):1155-9. PubMed ID: 21627894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olanzapine-Induced Neuroleptic Malignant Syndrome.
    Hosseini S; Elyasi F
    Iran J Med Sci; 2017 May; 42(3):306-309. PubMed ID: 28533580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic malignant syndrome with delayed onset of fever following risperidone administration.
    Norris B; Angeles V; Eisenstein R; Seale JP
    Ann Pharmacother; 2006 Dec; 40(12):2260-4. PubMed ID: 17119106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In the Balance: A Case of Neuroleptic Malignant Syndrome When Donepezil Is Added to Maintenance Haloperidol Decanoate.
    Mican LM; Schulenberg S
    J Pharm Technol; 2014 Dec; 30(6):235-239. PubMed ID: 34860886
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnostic and therapeutic challenges in neuroleptic malignant syndrome: a severe medical case.
    Brogna P; Colasuonno R; Di Michele F; Paterniti AM; Talamo A; Ribolsi M; Jannini TB; Siracusano A; Niolu C
    Riv Psichiatr; 2020; 55(4):236-239. PubMed ID: 32724236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic malignant syndrome induced by atypical neuroleptics and responsive to lorazepam.
    Yacoub A; Francis A
    Neuropsychiatr Dis Treat; 2006 Jun; 2(2):235-40. PubMed ID: 19412469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Four cases of neuroleptic malignant syndrome.
    McLean DR; Hafez MS; Duarte-Afara RR; Obeid ME
    Ann Saudi Med; 1992 Jan; 12(1):24-9. PubMed ID: 17589122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant Catatonia Versus Neuroleptic Malignant Syndrome.
    Desai S; Hirachan T; Toma A; Gerolemou A
    Cureus; 2021 Jun; 13(6):e15818. PubMed ID: 34306883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment of neuroleptic malignant syndrome.
    Guerrero RM; Shifrar KA
    Clin Pharm; 1988 Sep; 7(9):697-701. PubMed ID: 3240662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuroleptic malignant syndrome: case report with recurrence associated with the use of olanzapine].
    Hanel RA; Sandmann MC; Kranich M; De Bittencourt PR
    Arq Neuropsiquiatr; 1998 Dec; 56(4):833-7. PubMed ID: 10029891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic malignant syndrome due to olanzapine.
    Hall KL; Taylor WH; Ware MR
    Psychopharmacol Bull; 2001; 35(3):49-54. PubMed ID: 12397878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis and treatment of neuroleptic malignant syndrome.
    Ebadi M; Pfeiffer RF; Murrin LC
    Gen Pharmacol; 1990; 21(4):367-86. PubMed ID: 1974219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptic Malignant Syndrome Associated with Valproate in an Adolescent.
    Yıldırım V; Direk MÇ; Güneş S; Okuyaz Ç; Toros F
    Clin Psychopharmacol Neurosci; 2017 Feb; 15(1):76-78. PubMed ID: 28138117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiating effect of fluphenazine decanoate and risperidone on development of neuroleptic malignant syndrome.
    Liu PY; Wu PC; Chen CY; Chen YC
    Gen Hosp Psychiatry; 2011; 33(1):84.e5-7. PubMed ID: 21353143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.